PMI

Picard Medical, Inc.

$8.05

-4.62%
SectorHealthcareIndustryMedical DevicesCountryUnited States
OverviewAI BriefChartFinancialsExposureFilingsScoresNewsAnalystsInsidersOwnership

Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.

Source: Yahoo Finance
Q-Score21/ 100
Market Cap$19.8M
P/E—
Dividend Yield0.00%
52-Week Range—
Next Earnings—
Analysts—
Beta1.29
AI summary

Price & performance

1M+34.6%
3M+51.7%
YTD-91.5%
1Y-94.7%
52-week range—
Beta1.29
Full chart and returns against a benchmark

Q-Score

21/ 100

Quality against peers; 50 is the peer median.

Growth56
Risk13
Performance28
Valuation23
Profitability21
Leverage30
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$4.9M+12.5%
Net income-$27M
Net margin-546.6%-67.1 pts
Historical fundamentals

Red flags in filings

4active red flags
Going-concern doubtMar 30, 2026
Material weakness in controlsMar 30, 2026
Late filing noticeAug 17, 2026
Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US
United States100%
Largest customer43%
Regions, segments, customers and suppliers

Valuation

PMIIndustryP/E—29.61P/S3.143.49EV/EBITDA—18.38P/B11.533.39PEG——
Dividend yield0.00%
Every valuation metric